Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 14, 1999

View Archived Issues

Prophylaxis of venous thromboembolism with enoxaparin assessed in hospitalized patients

Maxamine treatment leads to tumor regression in preclinical model of prostate cancer

Novel photoprobe for locating sites of action of general anesthetics

MS-275: new benzamide inhibitor of histone deacetylase selected as development candidate

Nonimmunosuppressive cytokine synthesis inhibitor effective in murine model of septic shock

Pharmacokinetics, metabolism of E-5842 studied in animals

Alinastine: pharmacological properties indicate benefit in seasonal allergic rhinoconjunctivitis

CCK/gastrin receptor ligands developed at James Black Foundation

Cell Pathways continues to investigate apoptosis-promoting compounds for neoplastic diseases

Korean scientists present new compounds for depression and other CNS disorders

Endothelin antagonists described by BMS for hypertension, etc.

Isis and Abbott initiate collaboration for antisense drugs

Newly patented naphthyridines antagonize IL-4 and enhance G-CSF production

Kosan achieves research milestone in collaboration with PRI

Novel antiparasitic agents designed at Johns Hopkins

Potential benefit of riluzole in epilepsy investigated in animal model

Maxalt approved in Canada for migraine therapy

Ciba Vision and QLT initiate T-IND clinical program for Visudyne therapy

23rd IEC news: pharmacokinetics of remacemide in renal or hepatic insufficiency

XTL and Lilly to collaborate on HCV therapy research

Transgene commences phase I trial for treatment of cervical cancer

Alteon and Taisho enter option agreement for AGE crosslink breaker

Chiron seeks U.K. approval for meningitis vaccine

Alza stockholders to vote on merger with Abbott next week

Potential new antidepressant exhibits biphasic effects on 5-HT uptake and 5-HT1A receptors

The Cystic Fibrosis Foundation funds drug discovery program at Aurora

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...